Liberals and Conservatives to focus on affordability crisis in fall sitting
Recent poll results from Abacus Data show Conservatives leading by 15 as federal government disapproval jumps four points.
Can the Liberals use the return of the House to stop the bleeding?
The Liberal government has been plummeting in political opinion polling since the summer began.
Trudeau’s path back to glory
Parliament’s return could mark the moment the Liberals turn things around.
It’s time to step up on housing to get more homes built
Canada has the most expensive housing market and lowest housing stock per capita among G7 nations.
Green caucus priorities include congruently addressing climate and housing crisis
Failure to act on the climate emergency increases our costs, from extreme weather events costing billions of dollars each year, to inflation driven in part by climate events that destroy crops and reduce yields.
Bills on gun control, digital privacy, and Métis governments among business in busy fall for Parliamentary committees
House and Senate committees will be reviewing bills related to the overhaul of federal privacy laws, the carbon price on farm fuel, and the seizure of dangerous drugs in the postal system.
How summer shaped the fall sitting: old issues with new focus, and shifting party dynamics
While the key policy themes in Parliament are largely unchanged from June to September, some will re-emerge in autumn with sharper or more urgent focus.
Talent shortage a priority for biotech sector emerging from pandemic
Canada is likely to face a shortfall of about 65,000 workers in the bio-economy by 2029, according to BioTalent Canada.
Canada’s place in the world of biotechnology research and application is in jeopardy
Government of Canada funded scholarships and fellowships are the primary sources of income for many biotechnology researchers. To stem the brain-drain, Canada must significantly increase the value and number of graduate student scholarships and post-doctoral fellowships and to index them to the cost of living.
Can biotechnology put patients’ needs ahead of profits?
These are challenging dilemmas for a government that gutted a suite of policies designed to cap excessive drug prices, and that ‘waxed lyrical’ about the importance of accelerating vaccine access worldwide, then failed to support an intellectual property waiver that would expand global production of COVID-19 vaccines.
